Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.77 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclooctane SCHEMBL17142032 | 1.00 | ALDH1A1 (0.77) | ALDH1A1TDP1FFAR3TRPA1LMNA | |
| Cyclohexane SCHEMBL6936130 | 0.96 | ALDH1A1 (0.71) | ALDH1A1TDP1FFAR3TRPA1LMNA | |
| Butanone SCHEMBL1310 | 0.88 | — | — | |
| Butanone SCHEMBL1039820 | 0.88 | ALDH1A1 (1.00) | ALDH1A1TDP1FFAR3TRPA1LMNA | |
| Butanone SCHEMBL8379087 | 0.88 | ALDH1A1 (1.00) | ALDH1A1TDP1FFAR3TRPA1LMNA | |
| Butanone SCHEMBL1510153 | 0.88 | — | — | |
| Butanone SCHEMBL20557981 | 0.84 | — | — | |
| Butanone SCHEMBL21631022 | 0.84 | — | — | |
| Butanone SCHEMBL5386702 | 0.84 | — | — | |
| Butanone SCHEMBL22405658 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11414374-B2 | Crystalline forms of vilanterol trifenatate and processes for their preparation | HOVIONE SCIENTIA LIMITED (IE) | 2022-08-16 | — | — | US | claimed |
| CN-114685566-A | Benzene arsenic oxide crystal form I, crystal form II and crystal form III and preparation method thereof | 江苏挪贝肽医药科技有限公司 | 2022-07-01 | — | — | CN | claimed |
| US-20200148626-A1 | New Crystalline Forms of Vilanterol Trifenatate and Processes for Their Preparation | HOVIONE SCIENTIA LIMITED (IE) | 2020-05-14 | — | — | US | claimed |
| CN-108368316-B | Composition, laminate, packaging material for battery case, and battery | 三井化学株式会社 | 2024-07-16 | — | — | CN | disclosed |
| US-20240190815-A1 | CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO--PHENYLAMINO)-BENZAMIDE AND USES THEREOF | SPRINGWORKS THERAPEUTICS, INC. | 2024-06-13 | — | — | US | disclosed |
| CN-114729246-B | Adhesive for electronic tag and electronic tag | 三井化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024085235-A1 | METHOD FOR PRODUCING CYCLIC PEPTIDE CRYSTALS | 中外製薬株式会社 | 2024-04-25 | — | — | WO | disclosed |
| US-11884610-B2 | Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof | SPRINGWORKS THERAPEUTICS, INC. (US) | 2024-01-30 | — | — | US | disclosed |
| US-20230032403-A1 | CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO--PHENYLAMINO)-BENZAMIDE AND USES THEREOF | SpringWorks Therapeutics Inc. (US) | 2023-02-02 | — | — | US | disclosed |
| US-11414374-B2 | Crystalline forms of vilanterol trifenatate and processes for their preparation | HOVIONE SCIENTIA LIMITED (IE) | 2022-08-16 | — | — | US | disclosed |
| CN-114867806-A | Adhesive composition, heat-fusible member, and packaging material for secondary battery | 东亚合成株式会社 | 2022-08-05 | — | — | CN | disclosed |
| US-5066883-A | ELECTRON-EMITTING DEVICE WITH ELECTRON-EMITTING REGION INSULATED FROM ELECTRODES | CANON KABUSHIKI KAISHA (JP) | 1991-11-19 | — | — | US | disclosed |
| US-5023110-A | Process for producing electron emission device | CANON KABUSHIKI KAISHA (JP) | 1991-06-11 | — | — | US | disclosed |
| US-4857619-A | Fluorine containing polymer having a terminal ester group | PPG INDUSTRIES, INC. (US) | 1989-08-15 | — | — | US | disclosed |
| US-4770976-A | Phenanthroimidazole compounds, their preparation, photopolymerizable coating and recording materials, and lithographic layers produced using these | BASF AKTIENGESELLSCHAFT (DE) | 1988-09-13 | — | — | US | disclosed |
| US-4649081-A | FERROMAGNETIC POWDER; MODIFIED SILICON COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1987-03-10 | — | — | US | disclosed |
| US-4529563-A | Surface treatment | Fais, Robert G. (US) | 1985-07-16 | — | — | US | disclosed |
| US-4410565-A | THERMOPLASTIC RESIN, FERROMAGNETIC METAL | FUJI PHOTO FILM CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4089993-A | Method of forming a metallic thin film by electroless plating on a vinylidene chloride undercoat | FUJI PHOTO FILM CO., LTD. (JA) | 1978-05-16 | — | — | US | disclosed |
| US-3962276-A | ENZYME INHIBITORS | ELI LILLY AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11884610-B2 | Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof | NRAS, BRAF, KSR2 | ALDH1A1 3605/4885TDP1 2584/4885FFAR3 556/4885 |
| US-20230032403-A1 | CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO--PHENYLAMINO)-BENZAMIDE AND USES THEREOF | NRAS, BRAF, KSR2 | ALDH1A1 3360/4885TDP1 2177/4885FFAR3 497/4885 |
| US-20240190815-A1 | CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO--PHENYLAMINO)-BENZAMIDE AND USES THEREOF | NRAS, BRAF, KSR2 | ALDH1A1 3466/4885TDP1 2271/4885FFAR3 521/4885 |
| US-11414374-B2 | Crystalline forms of vilanterol trifenatate and processes for their preparation | PRKCD, PRKCQ, CYP24A1 | ALDH1A1 2905/4885TDP1 824/4885FFAR3 392/4885 |
| US-20200148626-A1 | New Crystalline Forms of Vilanterol Trifenatate and Processes for Their Preparation | PRKCD, PRKCQ, PDE12 | ALDH1A1 3195/4885TDP1 728/4885FFAR3 334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.